Escalon Medical Corp. Stock Other OTC
Equities
ESMC
US2960743050
Advanced Medical Equipment & Technology
Sales 2022 | 10.7M 14.64M | Sales 2023 | 12.18M 16.66M | Capitalization | 1.85M 2.54M |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | - 0 | EV / Sales 2022 | 0.14 x |
Net Debt 2022 | 611K 836K | Net Debt 2023 | 205 280.33 | EV / Sales 2023 | 0.15 x |
P/E ratio 2022 |
-28
x | P/E ratio 2023 |
8.37
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 98.1% |
Managers | Title | Age | Since |
---|---|---|---|
Richard DePiano
CEO | Chief Executive Officer | 58 | 00-10-31 |
Mark Wallace
DFI | Director of Finance/CFO | 55 | 96-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lisa Napolitano
BRD | Director/Board Member | 61 | 02-12-31 |
Richard DePiano
CEO | Chief Executive Officer | 58 | 00-10-31 |
David Jacovini
BRD | Director/Board Member | 48 | 18-02-12 |
1st Jan change | Capi. | |
---|---|---|
+0.59% | 207B | |
+3.92% | 181B | |
+30.07% | 155B | |
+32.42% | 112B | |
+1.98% | 64.42B | |
+19.65% | 54.38B | |
-1.86% | 47.43B | |
-9.53% | 37.17B | |
-1.28% | 34.81B |